Moderna Vaccine Explained

Moderna, flu vaccine and FDA

Moderna's mRNA flu vaccine backed by FDA advisers

The U.S. Food and Drug Administration's advisory panel is set to vote on whether the benefits of Moderna's flu vaccine outweigh its risks in older adults, after regulators reversed course on rejecting the drugmaker's initial application for the shot.

· 2h

Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine

· 16h · on MSN

FDA panel backs first-of-its-kind flu vaccine using mRNA technology

Reuters on MSN

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny

By Christy Santhosh and Mariam Sunny June 18 (Reuters) - The U.S. Food and Drug Administration's advisory panel is set to ...

CBS News

Moderna says FDA will now review its new flu vaccine, reversing earlier decision

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Moderna, flu vaccine and FDA

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny

Moderna says FDA will now review its new flu vaccine, reversing earlier decision

Trending now